Sur cette page
01AORT prix
02Aperçu
03Graphique
04Splits d'actions
05À propos
06Performance
07Valorisation et ratios
13Dividendes
14Bénéfices
15Fondamentaux complets
16États financiers
17Détenteurs institutionnels (13F)
18Activistes et détenteurs de 5%+
19Initiés de la société
20Détention d'ETF
21Consensus
22Pairs
23Actualités
26Mes métriques
AORT Artivion, Inc. Common Stock
NYSE · Health Care · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 7, 2026
$22,31
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$19,16Bas 52 semaines
$48,25Haut 52 semaines
Capitalisation Boursière (MRQ)
$1.12B
P/E (TTM)
-371.8
BPA (TTM)
$-0.06
Revenu (TTM)
$471M
vos badges
Fourchette 52 semaines
$19–$48
Note des analystes
BUY
Objectif de cours
$42
P/E
-371.8
ROE
-0.73%
Marge nette
-0.67%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
AORT Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$22.31
Capitalisation Boursière (MRQ)
$1.12B
P/E (TTM)
-371.8
BPA (TTM)
$-0.06
Revenu (TTM)
$471M
ROE (TTM)
-0.73%
Dette/Capitaux propres (MRQ)
0.8
Fourchette 52 semaines
$19–$48
AORT Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Splits d'actions
| Date ex-dividende | Division | Type |
|---|---|---|
| 28 décembre 2000 | 3-for-2 | Avant |
| 1 juillet 1996 | 2-for-1 | Avant |
À propos de Artivion, Inc. Common Stock Présentation de l'entreprise depuis Wikipedia
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
secteurHealth Care
industrieHealth Care
employés1 800
paysUS
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$441M2016-12-31 → 2025-12-31
BPA$0.212016-12-31 → 2025-12-31
Flux de trésorerie libre$839.0K2016-12-31 → 2025-12-31
Marge nette-0.67%2016-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | AORT | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -371.8moyenne 5 ans ≈5.0 | ≈5.0 | · | · | |
| P/S (TTM) | 2.4moyenne 5 ans ≈3.0 | ≈3.0 | 3.9 | Sous-évalué | |
| P/B (MRQ) | 2.5moyenne 5 ans ≈3.4 | ≈3.4 | 3.9 | Sous-évalué | |
| EV / EBITDA | 22.5moyenne 5 ans ≈32.6 | ≈32.6 | · | · | |
| Cours / FCF (TTM) | -122.3moyenne 5 ans ≈554.3 | ≈554.3 | · | · | |
| Cours / Flux de trésorerie (TTM) | 26.8moyenne 5 ans ≈-54.3 | ≈-54.3 | 38.0 | Surévalué | |
| EV / Revenue (VE / Chiffre d'affaires) | 2.9moyenne 5 ans ≈3.7 | ≈3.7 | · | · | |
| EV / FCF (VE / FCF) | 1508.1moyenne 5 ans ≈592.1 | ≈592.1 | · | · | |
| Cours / Actif net tangible (MRQ) | 3.8 | · | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | AORT | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge Brute (TTM) | 64.4%moyenne 5 ans ≈64.8% | ≈64.8% | 64.0% | En ligne | |
| Marge d'exploitation (TTM) | 4.4%moyenne 5 ans ≈4.8% | ≈4.8% | -7.6% | En ligne | |
| Marge EBITDA (TTM) | 9.6%moyenne 5 ans ≈11.4% | ≈11.4% | -7.6% | En ligne | |
| Marge avant impôts (TTM) | 0.47%moyenne 5 ans ≈-2.9% | ≈-2.9% | -8.7% | En ligne | |
| Marge nette (TTM) | -0.67%moyenne 5 ans ≈-4.2% | ≈-4.2% | -9.5% | En ligne | |
| ROA (TTM) | -0.33%moyenne 5 ans ≈-1.8% | ≈-1.8% | -20.2% | Premier rang | |
| ROE (TTM) | -0.73%moyenne 5 ans ≈-5.1% | ≈-5.1% | -25.1% | Premier rang | |
| ROIC | 3.4%moyenne 5 ans ≈3.8% | ≈3.8% | -31.3% | Premier rang |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | AORT | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Dette / Capitaux propres (MRQ) | 0.8moyenne 5 ans ≈1.0 | ≈1.0 | 0.6 | Endettement élevé | |
| Ratio de liquidité (MRQ) | 3.5moyenne 5 ans ≈4.6 | ≈4.6 | 5.6 | Faible liquidité | |
| Quick Ratio (Ratio de liquidité réduite) | 1.5moyenne 5 ans ≈2.0 | ≈2.0 | 3.6 | Faible liquidité | |
| Dette à long terme / Capitaux propres (MRQ) | 0.8moyenne 5 ans ≈1.0 | ≈1.0 | 0.6 | Endettement élevé |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | AORT | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | 13.6%moyenne 5 ans ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 12.0%moyenne 5 ans ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 11.8% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | AORT | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.5moyenne 5 ans ≈0.5 | ≈0.5 | 0.5 | En ligne | |
| Inventory Turnover (Rotation des stocks) | 1.8moyenne 5 ans ≈1.6 | ≈1.6 | 1.8 | En ligne | |
| Receivables Turnover (Rotation des créances) | 5.2moyenne 5 ans ≈5.4 | ≈5.4 | 6.9 | Faible | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$245.2K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Paiement annualisé≈$0.12
| Date ex-dividende | Montant | Devise | Rendement |
|---|---|---|---|
| Déc 9, 2015 | $0,03 | USD | ≈1.2% |
| Sep 9, 2015 | $0,03 | USD | ≈1.2% |
| Jui 10, 2015 | $0,03 | USD | ≈1.1% |
| Mar 11, 2015 | $0,03 | USD | ≈1.2% |
| Déc 10, 2014 | $0,03 | USD | ≈1.1% |
| Sep 10, 2014 | $0,03 | USD | ≈1.2% |
| Jui 11, 2014 | $0,03 | USD | ≈1.3% |
| Mar 12, 2014 | $0,03 | USD | ≈1.2% |
| Déc 11, 2013 | $0,03 | USD | ≈1.1% |
| Sep 11, 2013 | $0,03 | USD | ≈1.7% |
| Jui 12, 2013 | $0,03 | USD | ≈1.7% |
| Mar 12, 2013 | $0,03 | USD | ≈1.2% |
| Déc 12, 2012 | $0,03 | USD | ≈0.83% |
| Sep 12, 2012 | $0,03 | USD | ≈0.45% |
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-518.1%
Prochain rapport
Nov 04, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 5, 2026 | $-0.28 | $0.01 | -2845.1% |
| 31 mars 2026 | $0.03 | $0.05 | -40.1% | |
| 31 décembre 2025 | $0.05 | $0.08 | -40.0% | |
| 30 septembre 2025 | $0.06 | $0.02 | 242.9% | |
| 30 juin 2025 | $0.08 | $-0.00 | — | |
| 31 mars 2025 | $-0.01 | $-0.12 | 91.7% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.09 | $6.36 | $6.62 | $6.80 | $7.26 | $8.14 | $7.32 | $7.15 | $7.37 | $6.11 | · | $5.09 | |
| Revenue / Share | $9.36 | $9.32 | $8.69 | $7.84 | $7.67 | $6.69 | $7.30 | $7.22 | $5.55 | $5.50 | · | $5.11 | |
| Cash Flow / Share | $0.85 | $0.53 | $0.46 | $-0.13 | $-0.07 | $0.33 | $0.42 | $0.27 | $0.32 | $0.60 | · | $0.29 | |
| Cash / Share | $1.32 | $1.23 | $1.38 | $0.94 | $1.33 | $1.52 | $0.87 | $1.08 | $1.06 | $1.65 | · | $1.14 | |
| Dividend / Share | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $0.12 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | $0.12 | $0.12 | |
| EPS (TTM) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | · | 47,233,000 | 44,296,000 | 42,232,000 | · | 41,844,000 | 41,683,000 | 41,290,000 | · | 40,881,000 | 40,755,000 | 40,432,000 | · | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | · | 48,775,000 | 45,378,000 | 42,232,000 | · | 41,844,000 | 41,683,000 | 47,886,000 | · | 40,881,000 | 40,755,000 | 40,432,000 | · | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.88 | $9.01 | · | $8.98 | $8.64 | $6.66 | · | $7.02 | · | · | · | $6.39 | $6.66 | $6.61 | · | $6.10 | |
| Revenue / Share | $2.59 | $2.34 | · | $2.32 | $2.49 | $2.34 | · | $2.29 | $2.35 | $2.03 | · | $2.15 | $2.19 | $2.06 | · | $1.92 | |
| Cash Flow / Share | · | $0.02 | · | · | · | $-0.40 | · | · | · | $-0.11 | · | · | · | $-0.15 | · | · | |
| Cash / Share | $1.54 | $1.12 | · | $1.50 | $1.10 | $0.85 | · | $1.29 | · | · | · | $1.26 | $1.15 | $0.73 | · | $0.90 | |
| EPS (TTM) | $-0.06 | $0.25 | · | $-0.25 | $-0.43 | $-0.51 | · | $-0.02 | $-0.21 | $-0.24 | · | $-0.60 | $-0.70 | $-0.73 | · | $-1.03 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $471M | $459M | · | $423M | $405M | $390M | · | $385M | $377M | $368M | · | $340M | $329M | $320M | · | $314M | |
| Net Income TTM | $-3M | $12M | · | $-9M | $-18M | $-21M | · | $-851.0K | $-8M | $-10M | · | $-25M | $-28M | $-29M | · | $-41M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -374.5 | 146.5 | · | -169.4 | -72.3 | -48.2 | · | -1331.0 | -122.1 | -88.2 | · | -25.3 | -24.6 | -17.9 | · | -13.4 | |
| P/S | 2.4 | 4.0 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.8 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| EV / Revenue | 3.0 | 4.3 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.6 | 3.0 | 2.6 | · | 2.7 | |
| Dividend Yield | 0.30% | 0.19% | · | 0.16% | 0.23% | 0.31% | · | 0.30% | · | · | · | 0.53% | 0.47% | 0.61% | · | 0.59% | |
| Earnings Yield | -0.27% | 0.68% | · | -0.59% | -1.4% | -2.1% | · | -0.08% | -0.82% | -1.1% | · | -4.0% | -4.1% | -5.6% | · | -7.4% | |
| Annual Payout | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $441M | $389M | $354M | $314M | $299M |
| Marge Brute % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| Marge d'exploitation % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| Résultat net | $10M | $-13M | $-31M | $-19M | $-15M |
| BPA dilué | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| Ratio de liquidité | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| Ratio de liquidité réduite | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $839.0K | $11M | $11M | $-14M | $-16M |
Détenteurs institutionnels (13F) 212 déclarants · $1.2B total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
212
Valeur détenue
$1.2B
Nouvelles positions
34
Positions clôturées
65
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 34 (-7 vs T. préc.) | 65 (+29 vs T. préc.) | 81 (-12 vs T. préc.) | 56 (-7 vs T. préc.) | +2.0M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $149 965 153 | 6 674 017 | 12,78% | Actions |
| VANGUARD GROUP INC | $144 587 760 | 3 170 089 | 12,33% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71 566 000 | 3 184 974 | 6,10% | Actions |
| MORGAN STANLEY | $57 477 400 | 2 557 961 | 4,90% | Actions |
| Juniper Investment Company, LLC | $45 386 816 | 2 019 885 | 3,87% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $45 043 789 | 2 004 619 | 3,84% | Actions |
| FMR LLC | $44 119 203 | 1 963 471 | 3,76% | Actions |
| STATE STREET CORP | $41 750 406 | 1 858 051 | 3,56% | Actions |
| Ophir Asset Management Pty Ltd | $40 446 180 | 1 800 008 | 3,45% | Actions |
| PERCEPTIVE ADVISORS LLC | $39 036 906 | 1 737 290 | 3,33% | Actions |
| Conestoga Capital Advisors, LLC | $36 484 539 | 1 623 700 | 3,11% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $28 318 470 | 1 260 279 | 2,41% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $25 043 403 | 1 114 297 | 2,13% | Actions |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23 011 325 | 1 024 091 | 1,96% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22 205 281 | 988 219 | 1,89% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $21 300 127 | 947 941 | 1,82% | Actions |
| CITADEL ADVISORS LLC | $18 596 037 | 827 594 | 1,59% | Actions |
| YARGER WEALTH STRATEGIES, LLC | $15 278 432 | 634 223 | 1,30% | Actions |
| ROYCE & ASSOCIATES LP | $14 364 667 | 639 282 | 1,22% | Actions |
| NORTHERN TRUST CORP | $12 370 454 | 550 532 | 1,05% | Actions |
| BANK OF AMERICA CORP /DE/ | $11 716 689 | 521 437 | 1,00% | Actions |
| Qube Research & Technologies Ltd | $10 704 820 | 476 405 | 0,91% | Actions |
| FRED ALGER MANAGEMENT, LLC | $10 406 104 | 463 111 | 0,89% | Actions |
| UBS Group AG | $10 210 390 | 454 401 | 0,87% | Actions |
| TWO SIGMA ADVISERS, LP | $9 974 907 | 218 700 | 0,85% | Actions |
| Invesco Ltd. | $9 956 839 | 443 117 | 0,85% | Actions |
| GOLDMAN SACHS GROUP INC | $9 857 903 | 438 714 | 0,84% | Actions |
| D. E. Shaw & Co., Inc. | $9 846 714 | 438 216 | 0,84% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9 183 579 | 408 704 | 0,78% | Actions |
| Toroso Investments, LLC | $9 018 146 | 197 723 | 0,77% | Actions |
| Soleus Capital Management, L.P. | $8 718 360 | 388 000 | 0,74% | Actions |
| TWO SIGMA INVESTMENTS, LP | $8 702 159 | 387 279 | 0,74% | Actions |
| Balyasny Asset Management L.P. | $8 584 686 | 382 051 | 0,73% | Actions |
| First Eagle Investment Management, LLC | $7 787 496 | 346 573 | 0,66% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $6 978 103 | 310 552 | 0,59% | Actions |
| KENNEDY CAPITAL MANAGEMENT LLC | $6 611 371 | 294 231 | 0,56% | Actions |
| Legal & General Group Plc | $5 826 427 | 259 298 | 0,50% | Actions |
| WASATCH ADVISORS LP | $5 726 929 | 156 388 | 0,49% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $5 705 178 | 253 902 | 0,49% | Actions |
| Bank of New York Mellon Corp | $5 671 109 | 252 386 | 0,48% | Actions |
| Quantinno Capital Management LP | $4 497 191 | 200 142 | 0,38% | Actions |
| AMERIPRISE FINANCIAL INC | $4 348 978 | 193 546 | 0,37% | Actions |
| FIFTH THIRD BANCORP | $4 170 912 | 185 621 | 0,36% | Actions |
| ORBIMED ADVISORS LLC | $3 932 250 | 175 000 | 0,34% | Actions |
| Corient Private Wealth LP | $3 580 552 | 159 348 | 0,31% | Actions |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $3 324 253 | 90 777 | 0,28% | Actions |
| Public Sector Pension Investment Board | $3 298 304 | 146 787 | 0,28% | Actions |
| Parkman Healthcare Partners LLC | $3 121 982 | 138 940 | 0,27% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2 879 149 | 128 133 | 0,25% | Actions |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2 857 263 | 127 159 | 0,24% | Actions |
Activistes et détenteurs de 5%+ 5 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 dépôts | 12 août 2025 | 4,00% | Amendement | · | SEC |
| CryoLife, Inc., CL Falcon, Inc. | 11 mai 2011 | · | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | 10 juillet 2007 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 2 décembre 2005 | · | Dépôt initial | Investissement passif | SEC |
| Personne déclarante non divulguée | 18 mars 2005 | · | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 49 initiés · 30 dirigeants · 15 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | 19 août 2026 S | 877 275 | 0 | 9 | $-9 722 946 |
| Lance A Berry | EVP, COO, CFO & Treasurer | 14 août 2026 S | 210 112 | 0 | 5 | $-803 205 |
| David Ashley Lee | Executive VP, COO & CFO | 2 mars 2023 S | 347 217 | 0 | 0 | $0 |
| Andrew M Green | SVP, Regulatory and Quality | 10 septembre 2026 S | 40 160 | 0 | 6 | $-1 431 215 |
| Jean F Holloway | SVP, General Counsel | 12 août 2026 S | 184 118 | 0 | 13 | $-2 537 794 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | 3 mars 2026 S | 60 097 | 0 | 13 | $-3 426 956 |
| John E Davis | Chief Commercial Officer | 3 mars 2026 S | 230 794 | 0 | 9 | $-1 745 924 |
| Amy Horton | VP, Chief Accounting Officer | 3 mars 2026 S | 139 088 | 0 | 8 | $-870 080 |
| Matthew A Getz | VP, Human Resources | 16 août 2024 S | 34 116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | 27 février 2024 S | 21 558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | 26 février 2024 S | 44 518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | 23 février 2024 A | 13 291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | 6 juin 2023 S | 34 724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | 8 novembre 2022 A | 32 516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | 12 mars 2021 F | 153 203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | 14 mars 2019 F | 30 806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | 14 mars 2019 F | 25 084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | 5 mars 2018 F | 39 883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | 16 novembre 2017 M | 77 135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | 9 avril 2015 F | 1 271 846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | 7 mars 2015 F | 42 106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | 7 mars 2015 F | 110 559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | 26 février 2015 A | 73 441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | 15 août 2014 M | 95 221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | 30 novembre 2012 S | 71 999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | 31 décembre 2011 F | 110 144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | 4 septembre 2007 A | 23 100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | 18 janvier 2006 M | 42 728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | 21 septembre 2004 M | 55 131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | 14 septembre 2004 M | 36 165 | 0 | 0 | $0 |
| Anthony B. Semedo | Administrateur | 2 juin 2026 J | 6 325 | 0 | 0 | $0 |
| Elizabeth A Hoff | Administrateur | 18 mai 2026 A | 34 765 | 0 | 1 | $-189 420 |
| Marna P Borgstrom | Administrateur | 18 mai 2026 A | 56 664 | 0 | 0 | $0 |
| Jon W Salveson | Administrateur | 18 mai 2026 A | 137 416 | 0 | 0 | $0 |
| Jeffrey H Burbank | Administrateur | 18 mai 2026 A | 61 372 | 0 | 0 | $0 |
| Daniel J Bevevino | Administrateur | 18 mai 2026 A | 157 637 | 0 | 0 | $0 |
| Bullock James | Administrateur | 18 mai 2026 A | 76 223 | 0 | 0 | $0 |
| Thomas F Ackerman | Administrateur | 18 mai 2026 A | 157 472 | 0 | 0 | $0 |
| Harvey Morgan | Administrateur | 30 août 2021 G | 46 342 | 0 | 0 | $0 |
| Ronald D Mccall | Administrateur | 25 août 2021 S | 121 768 | 0 | 0 | $0 |
| Elkins C Ronald | Administrateur | 5 septembre 2018 S | 64 843 | 0 | 0 | $0 |
| James Benson | Administrateur | 2 octobre 2017 S | 54 086 | 0 | 0 | $0 |
| John M Cook | Administrateur | 9 juin 2009 M | 85 000 | 0 | 0 | $0 |
| LACY VIRGINIA C | Administrateur | 24 avril 2007 S | 255 280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | Administrateur | 1 août 2006 A | 12 800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | Détenteur de 10% | 31 mai 2007 S | 1 918 000 | 0 | 0 | $0 |
| Michael S Simpson | · | 5 mars 2021 F | 33 698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | · | 5 mai 2020 A | 23 451 | 0 | 0 | $0 |
| Thomas J Lynch | · | 2 novembre 2004 A | 5 000 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 36 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,64% | 42 246 NS | 31 juillet 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,59% | 46 432 SH | 2 octobre 2026 | Quotidien |
| RZG · Invesco Exchange-Traded Fund Trust | 0,40% | 21 951 SH | 2 octobre 2026 | Quotidien |
| EBIT · Harbor ETF Trust | 0,25% | 1 133 NS | 31 juillet 2026 | N-PORT |
| ESSC · Strategy Shares | 0,17% | 2 304 NS | 31 juillet 2026 | N-PORT |
| IHI · iShares Trust | 0,16% | 203 954 SH | 11 septembre 2026 | Quotidien |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,10% | 50 848 SH | 19 août 2026 | Quotidien |
| IWO · iShares Trust | 0,07% | 429 440 SH | 11 septembre 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 49 054 SH | 19 août 2026 | Quotidien |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 148 966 SH | 19 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,04% | 21 860 NS | 31 juillet 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 14 453 SH | 11 septembre 2026 | Quotidien |
| IWM · iShares Trust | 0,04% | 1 164 969 SH | 11 septembre 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 263 046 SH | 19 août 2026 | Quotidien |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,03% | 23 979 SH | 2 octobre 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 30 302 SH | 2 octobre 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,02% | 124 676 NS | 31 juillet 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 20 435 NS | 31 juillet 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 495 296 SH | 19 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,01% | 127 662 SH | 19 août 2026 | Quotidien |
| WSML · iShares Trust | 0,01% | 2 287 SH | 11 septembre 2026 | Quotidien |
| DXUV · Dimensional ETF Trust | 0,01% | 1 400 NS | 31 juillet 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 90 038 NS | 31 juillet 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 3 634 NS | 31 juillet 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4 761 NS | 31 juillet 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 9 530 NS | 31 juillet 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13 831 NS | 31 juillet 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 61 878 SH | 11 septembre 2026 | Quotidien |
| IWV · iShares Trust | 0,00% | 10 858 SH | 11 septembre 2026 | Quotidien |
| DFAT · Dimensional ETF Trust | 0,00% | 2 692 NS | 31 juillet 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 463 340 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 652 SH | 19 août 2026 | Quotidien |
| IJR · iShares Trust | · | 2 603 782 SH | 10 septembre 2026 | Quotidien |
| IJT · iShares Trust | · | 403 685 SH | 9 septembre 2026 | Quotidien |
| XJR · iShares Trust | · | 5 899 SH | 2 septembre 2026 | Quotidien |
| ISCB · iShares Trust | · | 2 111 SH | 11 septembre 2026 | Quotidien |
AORT Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 14 analystes
ACHAT
Objectif médian
$42.00
+88,3%
5 35,7%
Achat fort
8 57,1%
Achat
1 7,1%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
8 analystes · 2026-09-29Objectif moyen $42.15 +88,9%
← En dessous de tous les objectifs
Prix actuel $22.31
Bas$38.00
Moyenne$42.15
Haut$48.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| IART | · | -1.8 | 1.5% | -31.6% | -49.6% | · |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 7, 2026